466 related articles for article (PubMed ID: 34554778)
1. Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice.
Chen Y; Lüttmann FF; Schoger E; Schöler HR; Zelarayán LC; Kim KP; Haigh JJ; Kim J; Braun T
Science; 2021 Sep; 373(6562):1537-1540. PubMed ID: 34554778
[TBL] [Abstract][Full Text] [Related]
2. Reprogramming factors induce proliferation and inhibit apoptosis of melanoma cells by changing the expression of particular genes.
Wang Y; Sun HJ; Li RG; Wang XM; Cheng ZQ; Lou N
Mol Med Rep; 2019 Feb; 19(2):967-973. PubMed ID: 30569122
[TBL] [Abstract][Full Text] [Related]
3. Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like Cells.
Ghazizadeh Z; Rassouli H; Fonoudi H; Alikhani M; Talkhabi M; Darbandi-Azar A; Chen S; Baharvand H; Aghdami N; Salekdeh GH
Mol Biotechnol; 2017 Jun; 59(6):207-220. PubMed ID: 28509990
[TBL] [Abstract][Full Text] [Related]
4. Generation of Induced Cardiospheres via Reprogramming of Skin Fibroblasts for Myocardial Regeneration.
Xu JY; Lee YK; Ran X; Liao SY; Yang J; Au KW; Lai WH; Esteban MA; Tse HF
Stem Cells; 2016 Nov; 34(11):2693-2706. PubMed ID: 27333945
[TBL] [Abstract][Full Text] [Related]
5. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4.
Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P
Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023
[TBL] [Abstract][Full Text] [Related]
6. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
[TBL] [Abstract][Full Text] [Related]
7. Molecular insights into reprogramming-initiation events mediated by the OSKM gene regulatory network.
Mah N; Wang Y; Liao MC; Prigione A; Jozefczuk J; Lichtner B; Wolfrum K; Haltmeier M; Flöttmann M; Schaefer M; Hahn A; Mrowka R; Klipp E; Andrade-Navarro MA; Adjaye J
PLoS One; 2011; 6(8):e24351. PubMed ID: 21909390
[TBL] [Abstract][Full Text] [Related]
8. Targeting of apoptosis gene loci by reprogramming factors leads to selective eradication of leukemia cells.
Wang Y; Lu T; Sun G; Zheng Y; Yang S; Zhang H; Hao S; Liu Y; Ma S; Zhang H; Ru Y; Gao S; Yen K; Cheng H; Cheng T
Nat Commun; 2019 Dec; 10(1):5594. PubMed ID: 31811153
[TBL] [Abstract][Full Text] [Related]
9. ONSL and OSKM cocktails act synergistically in reprogramming human somatic cells into induced pluripotent stem cells.
Jung L; Tropel P; Moal Y; Teletin M; Jeandidier E; Gayon R; Himmelspach C; Bello F; André C; Tosch A; Mansouri A; Bruant-Rodier C; Bouillé P; Viville S
Mol Hum Reprod; 2014 Jun; 20(6):538-49. PubMed ID: 24501429
[TBL] [Abstract][Full Text] [Related]
10. A Versatile In Vivo System to Study Myc in Cell Reprogramming.
Senís E; Mosteiro L; Grimm D; Abad M
Methods Mol Biol; 2021; 2318():267-279. PubMed ID: 34019296
[TBL] [Abstract][Full Text] [Related]
11. Understanding impediments to cellular conversion to pluripotency by assessing the earliest events in ectopic transcription factor binding to the genome.
Soufi A; Zaret KS
Cell Cycle; 2013 May; 12(10):1487-91. PubMed ID: 23603987
[TBL] [Abstract][Full Text] [Related]
12. Krüppel-like factor 1 is a core cardiomyogenic trigger in zebrafish.
Ogawa M; Geng FS; Humphreys DT; Kristianto E; Sheng DZ; Hui SP; Zhang Y; Sugimoto K; Nakayama M; Zheng D; Hesselson D; Hodson MP; Bogdanovic O; Kikuchi K
Science; 2021 Apr; 372(6538):201-205. PubMed ID: 33833125
[TBL] [Abstract][Full Text] [Related]
13. C/EBPα poises B cells for rapid reprogramming into induced pluripotent stem cells.
Di Stefano B; Sardina JL; van Oevelen C; Collombet S; Kallin EM; Vicent GP; Lu J; Thieffry D; Beato M; Graf T
Nature; 2014 Feb; 506(7487):235-9. PubMed ID: 24336202
[TBL] [Abstract][Full Text] [Related]
14. OSKM Induce Extraembryonic Endoderm Stem Cells in Parallel to Induced Pluripotent Stem Cells.
Parenti A; Halbisen MA; Wang K; Latham K; Ralston A
Stem Cell Reports; 2016 Apr; 6(4):447-455. PubMed ID: 26947975
[TBL] [Abstract][Full Text] [Related]
15. Sox2 transduction enhances cardiovascular repair capacity of blood-derived mesoangioblasts.
Koyanagi M; Iwasaki M; Rupp S; Tedesco FS; Yoon CH; Boeckel JN; Trauth J; Schütz C; Ohtani K; Goetz R; Iekushi K; Bushoven P; Momma S; Mummery C; Passier R; Henschler R; Akintuerk H; Schranz D; Urbich C; Galvez BG; Cossu G; Zeiher AM; Dimmeler S
Circ Res; 2010 Apr; 106(7):1290-302. PubMed ID: 20185800
[TBL] [Abstract][Full Text] [Related]
16. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM
Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the roadmap of in vivo reprogramming toward pluripotency.
Chondronasiou D; Martínez de Villarreal J; Melendez E; Lynch CJ; Pozo ND; Kovatcheva M; Aguilera M; Prats N; Real FX; Serrano M
Stem Cell Reports; 2022 Nov; 17(11):2501-2517. PubMed ID: 36270281
[TBL] [Abstract][Full Text] [Related]
18. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
[TBL] [Abstract][Full Text] [Related]
19. In vivo partial reprogramming of myofibers promotes muscle regeneration by remodeling the stem cell niche.
Wang C; Rabadan Ros R; Martinez-Redondo P; Ma Z; Shi L; Xue Y; Guillen-Guillen I; Huang L; Hishida T; Liao HK; Nuñez Delicado E; Rodriguez Esteban C; Guillen-Garcia P; Reddy P; Izpisua Belmonte JC
Nat Commun; 2021 May; 12(1):3094. PubMed ID: 34035273
[TBL] [Abstract][Full Text] [Related]
20. OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition.
Teshigawara R; Hirano K; Nagata S; Ainscough J; Tada T
Development; 2016 Jan; 143(1):15-23. PubMed ID: 26657769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
